UBS Didn't Earn $7.8M Transaction Fee: Stem Cell Co.
Angioblast Systems Inc. told a New York state judge Friday that UBS Securities LLC is not entitled to $7.8 million in transaction fees because the bank did not live up to...To view the full article, register now.
Already a subscriber? Click here to view full article